Biovision – Identifying  and Funding  Disruptive Innovation in Healthcare

Biovision, the annual forum devoted to future-oriented research in life sciences, is launching this years’ registration campaign and its call for applications for innovative projects and companies. This year’s event will take place in Lyon, France, on June 5 and 6, 2014.
The World Life Sciences forum attracts a wide range of innovative companies seeking funding, partners and broader industry exposure. This year, it will bring together international decision-makers from the academic, policy-making, civil society and private sectors to discuss the effects of ‘disruptive innovation’.

New in 2014, two special sessions will also raise awareness and educate the general public on the scientific issues of tomorrow. High quality panelists from all over the world will debate the two key future-oriented themes of 2014: ‘immunotherapies’ and ’healthy ageing’.
  
By popular demand, the Biovision Investor Conference is returning for a second edition this year. Dedicated to funding for innovative businesses, it will connect start-ups, growth companies and mid-sized businesses with financial and industry partners in a series of discussions and meetings. Biovision, in partnership with world-class bio-cluster Lyonbiopole, is also organising the second Catalyzer conference, which showcases innovative collaborative projects. Two sessions will provide increased exposure for immunology and ’healthy aging’ project owners and offer new opportunities to meet with potential partners.
 
“Biovision reflects a desire to move from thoughts to action,” explains Alain Merieux, chairman of the Fondation pour l'Universite de Lyon and the Institut Merieux. “With this in mind, it is a place where multiple stakeholders can meet, be they from academia, the policy or private sectors, or from civil society - which also needs to understand the complexity of our professional challenges.”
 
The final list of project holders and companies selected to present at Biovision will be announced on April 21 for Catalyzer and on May 5 for the Investor Conference.
More information: http://www.biovision.org